WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

3.24.26

Wilson Sonsini Advises Spade on $40 Million Series B
On March 24, 2026, Spade, the data and AI platform transforming how financial institutions use transaction data, announced $40 million in Series B funding. The round was led by Oak HC/FT, with participation by Andreessen Horowitz, Flourish, Gradient, NAventures, National Bank of Canada’s corporate venture arm, and Y Combinator. Wilson Sonsini Goodrich & Rosati advised Spade on the transaction.
Client Highlights

12.31.25

Wilson Sonsini Advises BriefCatch on $6 Million Series A
On December 29, 2025, BriefCatch, a legal-writing platform used by law firms and courts, announced it has raised $6 million in Series A financing, representing a significant up round. The round was led by Full In, a software-focused growth equity firm. Wilson Sonsini Goodrich & Rosati advised BriefCatch on the transaction.

The Series A investment will support the continued development of BriefCatch's legal-writing platform and help advance the company's long-term vision of a more comprehensive, integrated set of AI-assisted writing tools for legal professionals.

The Wilson Sonsini team that advised BriefCatch on the transaction included Daniel Keating, Salil Gandhi, Brett Schulman, and Patrick Mullery.

For more information, please see BriefCatch’s news release.
Client Highlights

7.14.25

Wilson Sonsini Advises Windsurf on Acquisition by Cognition AI
On July 14, 2025, Cognition announced that it has signed a definitive agreement to acquire Windsurf, the agentic IDE. The acquisition includes Windsurf's IP, product, trademark, and brings the full Windsurf team to Cognition. Wilson Sonsini advised Windsurf on the transaction.
Client Highlights

1.28.25

Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing
On January 28, 2025, Ascentage Pharma Group International announced the closing of its U.S. initial public offering of 7,325,000 American depositary shares (ADSs) at a public offering price of $17.25 per ADS, before underwriting discounts and commissions. Each ADS represents four ordinary shares of Ascentage Pharma. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ascentage Pharma, were approximately $126.4 million. In addition, Ascentage Pharma has granted the underwriters a 30-day option to purchase up to an additional 1,098,750 ADSs at the initial public offering price, less underwriting discounts and commissions. The ADSs began trading on the Nasdaq Global Market on January 24, 2025.
Client Highlights

12.22.23

Firm Advises Sudo Biosciences on IP Matters Related to $116 Million Series B
On December 20, 2023, Sudo Biosciences, a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, announce
Client Highlights

1.20.23

Wilson Sonsini Advises Welcome Homes on $29 Million Series A
On January 12, 2023, Welcome Homes, a New York City-based proptech company that delivers luxurious homes at a guaranteed price in just a few clicks, announced that it has raised more than $29 million in Series A funding, led by Era Ventures. The funding round also included participation from Parker89, Montage Ventures, Foundamental, Global Founders Capital, Activant Capital, Gaingels, Elefund, and Arkin Holdings. Wilson Sonsini Goodrich & Rosati advised Welcome Homes on the transaction.
Client Highlights

11.11.21

Wilson Sonsini Advises KnowBe4 on Upsized Follow-On Offering
On November 10, 2021, KnowBe4, Inc., provider of the leading security awareness training and simulated phishing platform, announced the pricing of its previously announced underwritten public offering of 8,000,000 shares of its Class A common stock by certain selling stockholders at a price to the public of $25.75 per share. The offering was upsized from a previously announced offering size of 7,000,000 shares. Wilson Sonsini Goodrich & Rosati advised KnowBe4 on the transaction.

The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Class A common stock on the same terms and conditions. The offering is expected to close on November 15, subject to customary closing conditions. KnowBe4 will not receive any proceeds from any sales of shares by the selling stockholders.

The Wilson Sonsini team that advised KnowBe4 on the offering includes Megan Baier, David Sharon, Courtney Matteson, Brett Schulman, and McKenna Pruitt.

For more information, please see KnowBe4’s press release.
Client Highlights

11.11.20

Wilson Sonsini Advises Better.com in $200 Million Series D
On November 11, 2020, Better.com, one of the fastest-growing homeownership platforms in the country, announced a $200 million Series D round of funding. L Catterton served as lead investor, joining existing shareholders Activant Capital, Ally Financial, American Express Ventures, Ping An Global Voyager Fund, and 9Yards Capital in the round. The new investment round comes amid a period of significant growth for Better.com; over the last year, the company has grown its funded loan volume over four-fold. Wilson Sonsini Goodrich & Rosati represented Better.com in the transaction.
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.